Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. (2017)

First Author: Roseman L
Attributed to:  Psilocybin as a treatment for major depression funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2017.00974

PubMed Identifier: 29387009

Publication URI: http://europepmc.org/abstract/MED/29387009

Type: Journal Article/Review

Volume: 8

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812